Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2017 Mar 23

PMID 28326075

Citations 36

Authors

Suresh Panthee

Atmika Paudel

Hiroshi Hamamoto

Kazuhisa Sekimizu

Affiliations

Soon will be listed here.

Abstract

The demand for novel antibiotics to combat the global spread of multi drug-resistant pathogens continues to grow. Pathogenic bacteria and fungi that cause fatal human infections can also kill silkworms and the infected silkworms can be cured by the same antibiotics used to treat infections in the clinic. As an invertebrate model, silkworm model is characterized by its convenience, low cost, no ethical issues. The presence of conserved immune response and similar pharmacokinetics compared to mammals make silkworm infection model suitable to examine the therapeutic effectiveness of antimicrobial agents. Based on this, we utilized silkworm bacterial infection model to screen the therapeutic effectiveness of various microbial culture broths and successfully identified a therapeutically effective novel antibiotic, lysocin E, which has a novel mode of action of binding to menaquinone, thus leading to membrane damage and bactericidal activity. The similar approach to screen potential antibiotics resulted in the identification of other therapeutically effective novel antibiotics, such as nosokomycin and ASP2397 (VL-2397). In this regard, we propose that the silkworm antibiotic screening model is very effective for identifying novel antibiotics. In this review, we summarize the advantages of the silkworm model and propose that the utilization of silkworm infection model will facilitate the discovery of novel therapeutically effective antimicrobial agents.

Citing Articles

Dual Drug Loaded Topical Cubosomal Gel Against Candida Albicans: An In Vitro and In Vivo Proof of Concept.

Nath A, Vaiphei K, Kumar A, Basrani S, Jadhav A, Chakravarti R AAPS PharmSciTech. 2025; 26(3):77.

PMID: 40045107 DOI: 10.1208/s12249-025-03070-2.

Towards a Rational Basis for the Selection of Probiotics to Improve Silkworm Health and Performance.

Suraporn S, Liu J, Ren F, Wang L, Feng M, Terenius O Insects. 2025; 16(2).

PMID: 40003792 PMC: 11856270. DOI: 10.3390/insects16020162.

Proteomic Analysis of Midgut of Silkworm Reared on Artificial Diet and Mulberry Leaves and Functional Study of Three Genes.

Zhang S, Zhang X, Liang J, Huang S, Huang B, Ren C Int J Mol Sci. 2025; 26(3).

PMID: 39941077 PMC: 11818671. DOI: 10.3390/ijms26031309.

Discovery of new AMR drugs targeting modulators of antimicrobial activity using in vivo silkworm screening systems.

Tabuchi F, Mikami K, Miyauchi M, Sekimizu K, Miyashita A J Antibiot (Tokyo). 2024; 78(2):69-77.

PMID: 39543333 PMC: 11769840. DOI: 10.1038/s41429-024-00788-2.

Impact of Neem Seed Extract on Mortality, Esterase and Glutathione-S-Transferase Activities in Thai Polyvoltine Hybrid Silkworm, L.

Rattanapan A, Sujayanont P Insects. 2024; 15(8).

PMID: 39194796 PMC: 11354677. DOI: 10.3390/insects15080591.

References

Xu H, OBrochta D . Advanced technologies for genetically manipulating the silkworm Bombyx mori, a model Lepidopteran insect. Proc Biol Sci. 2015; 282(1810). PMC: 4590473. DOI: 10.1098/rspb.2015.0487. View

Altman G, Diaz F, Jakuba C, Calabro T, Horan R, Chen J . Silk-based biomaterials. Biomaterials. 2002; 24(3):401-16. DOI: 10.1016/s0142-9612(02)00353-8. View

Kaito C, Kurokawa K, Matsumoto Y, Terao Y, Kawabata S, Hamada S . Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol. 2005; 56(4):934-44. DOI: 10.1111/j.1365-2958.2005.04596.x. View

Ishii K, Hamamoto H, Sekimizu K . Paralytic peptide: an insect cytokine that mediates innate immunity. Arch Insect Biochem Physiol. 2014; 88(1):18-30. DOI: 10.1002/arch.21215. View

Ishii K, Adachi T, Hamamoto H, Oonishi T, Kamimura M, Imamura K . Insect cytokine paralytic peptide activates innate immunity via nitric oxide production in the silkworm Bombyx mori. Dev Comp Immunol. 2012; 39(3):147-53. DOI: 10.1016/j.dci.2012.10.014. View

Takasu Y, Kobayashi I, Tamura T, Uchino K, Sezutsu H, Zurovec M . Precise genome editing in the silkworm Bombyx mori using TALENs and ds- and ssDNA donors - A practical approach. Insect Biochem Mol Biol. 2016; 78:29-38. DOI: 10.1016/j.ibmb.2016.08.006. View

Xia Q, Zhou Z, Lu C, Cheng D, Dai F, Li B . A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science. 2004; 306(5703):1937-40. DOI: 10.1126/science.1102210. View

Kurokawa K, Hamamoto H, Matsuo M, Nishida S, Yamane N, Lee B . Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model. Antimicrob Agents Chemother. 2009; 53(9):4025-7. PMC: 2737873. DOI: 10.1128/AAC.00200-09. View

Hamamoto H, Kurokawa K, Kaito C, Kamura K, Razanajatovo I, Kusuhara H . Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob Agents Chemother. 2004; 48(3):774-9. PMC: 353159. DOI: 10.1128/AAC.48.3.774-779.2004. View

10.

Arendrup M, Jensen R, Cuenca-Estrella M . In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms. Antimicrob Agents Chemother. 2015; 60(1):532-6. PMC: 4704222. DOI: 10.1128/AAC.02336-15. View

11.

Hossain M, Hamamoto H, Matsumoto Y, Razanajatovo I, Larranaga J, Kaito C . Use of silkworm larvae to study pathogenic bacterial toxins. J Biochem. 2006; 140(3):439-44. DOI: 10.1093/jb/mvj171. View

12.

Matsumoto Y, Miyazaki S, Fukunaga D, Shimizu K, Kawamoto S, Sekimizu K . Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans. J Appl Microbiol. 2011; 112(1):138-46. DOI: 10.1111/j.1365-2672.2011.05186.x. View

13.

Hoffmann J, Reichhart J . Drosophila innate immunity: an evolutionary perspective. Nat Immunol. 2002; 3(2):121-6. DOI: 10.1038/ni0202-121. View

14.

Panthee S, Hamamoto H, Suzuki Y, Sekimizu K . In silico identification of lysocin biosynthetic gene cluster from Lysobacter sp. RH2180-5. J Antibiot (Tokyo). 2016; 70(2):204-207. DOI: 10.1038/ja.2016.102. View

15.

. The genome of a lepidopteran model insect, the silkworm Bombyx mori. Insect Biochem Mol Biol. 2009; 38(12):1036-45. DOI: 10.1016/j.ibmb.2008.11.004. View

16.

Usui K, Nishida S, Sugita T, Ueki T, Matsumoto Y, Okumura H . Acute oral toxicity test of chemical compounds in silkworms. Drug Discov Ther. 2016; 10(1):57-61. DOI: 10.5582/ddt.2016.01025. View

17.

Kato T, Kajikawa M, Maenaka K, Park E . Silkworm expression system as a platform technology in life science. Appl Microbiol Biotechnol. 2009; 85(3):459-70. PMC: 2802491. DOI: 10.1007/s00253-009-2267-2. View

18.

Paudel A, Hamamoto H, Panthee S, Sekimizu K . Menaquinone as a potential target of antibacterial agents. Drug Discov Ther. 2016; 10(3):123-8. DOI: 10.5582/ddt.2016.01041. View

19.

Kaito C, Akimitsu N, Watanabe H, Sekimizu K . Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog. 2002; 32(4):183-90. DOI: 10.1006/mpat.2002.0494. View

20.

Paudel A, Kaneko K, Watanabe A, Matsunaga S, Shigeki M, Kanai M . Structure-activity relationship study of novel iminothiadiazolo-pyrimidinone antimicrobial agents. J Antibiot (Tokyo). 2013; 66(11):663-7. DOI: 10.1038/ja.2013.69. View